Functional neuroimaging for clinical evaluation of mild‐to‐moderate toxic encephalopathic brain disease: A study of seven patients

References

• Baldi I., Filleul L., Mohammed‐Brahmin B., Fabriogoule C., Dartigues J. F., Schwall S., Drevet J. P., Salamon R., Brochard P. Neuropsychologic effects of long‐term exposure to pesticides: results from the French phytoner study. Environ Health Perspect 2001; 109((8))839–44
   PubMed Web of Science ®Google Scholar
• Farahat T., Abdelrasoul C., Amr R., Shebl M., Farahat F., Anger W. Neurobehavorial effects among workers occupationally exposed to organophosphate pesticides. Occup Environ Med 2003; 60((4))279–86
   PubMed Web of Science ®Google Scholar
• Rohlman D., Bailey S. R., Anger W. K., McCauley L. Assessment of neurobehavorial function with computerized tests in a population of Hispanic adolescents working in agriculture. Environ Res, Section A 2001; 85((1))14–24
   PubMed Web of Science ®Google Scholar
• Bazylewicz‐Walczak B., Majczakowak W., Szymczak M. Behavioral effects of occupational exposure to organophosphorus pesticides in female greenhouse planting workers. Neurotoxicology 1999; 20((5))819–26
   PubMed Web of Science ®Google Scholar
• Stallones L., Beseler C. Pesticide poisoning and depressive symptoms among farm residents. Ann Epidemiol 2002; 12((6))389–94
   PubMed Web of Science ®Google Scholar
• Morrow L., Stein L., Bogovich G., Condray R., Scott A. Neuropsychological assessment, depression and past exposure to organic solvents. Appl Neuropsych 2001; 8((1))65–73
   PubMedGoogle Scholar
• Morrow L., Gibson C., Bogovich G., Stein L., Condray R., Scott L. Increased incidence of anxiety and depressive disorders among persons with organic solvent exposure. Psychosomatic Med 2000; 62((5))746–50
   PubMedGoogle Scholar
• Ruijten M. W., Hooisma J., Brons J. T., Habets C. E., Emmen H. H., Muijser H. Neurobehavorial effects of long‐term exposure to xylene and mixed organic solvents in shipyard spray painters. Neurotoxicology 1994; 15((3))613–20
   PubMed Web of Science ®Google Scholar
• Hakkola M. Neuropsychological symptoms among tanker drivers with exposure to solvents. Occup Med (London) 1994; 44((5))243–6
   PubMedGoogle Scholar
• Escalona E., Yanes L., Feo O., Maizlish N. Neurobehavorial evaluation of Venezuelan workers exposed to organic solvent mixtures. Am J Ind Med 1995; 27((1))15–27
   PubMed Web of Science ®Google Scholar
• Eller N., Netterstrom B., Laursen P. Risk of chronic effects on the central nervous system at low toluene exposure. Occup Med (London) 1999; 49((6))389–95
   PubMed Web of Science ®Google Scholar
• Canfield R., Henderson C., Cory‐Slechta D., Cox C., Jusko T., Lanphear B. Intellectual impairment in children with blood lead concentrations below 10 ug per deciliter. New Engl J Med 2003; 348((16))1517–26
   PubMed Web of Science ®Google Scholar
• Stretesky P., Lynch M. The relationship between lead exposure and homicide. Arch Ped Adolesc Med 2001; 155((5))579–82
   PubMedGoogle Scholar
• Needleman H., Reiss J., Tobin M., Diesceker G., Greenhouse J. Bone lead levels and delinquent behavior. JAMA 1996; 275((5))363–9
   PubMed Web of Science ®Google Scholar
• Amitai Y., Zlotgorski Z., Golan V., Wexler A., Gross D. Neuropsychological impairment from acute low‐level exposure to carbon monoxide. Arch Neurol 1998; 55((6))845–8
   PubMedGoogle Scholar
• Devine S., Kirkley S., Palumbo C., White R. MRI and neuropsychological correlates of carbon monoxide exposure: a case report. Environ Health Perspect 2002; 110((10))1051–5
   PubMed Web of Science ®Google Scholar
• Gray M., Kilburn K., Crago R. Molds, mycotoxins and public health: Summary of 195 patients treated collaboratively. 2002, Presented 11 November 2002 at the American Public Health Association (APHA) meeting in Philadelphia, PA
   Google Scholar
• Gordon W., Johanning E., Haddad L. Cognitive impairment associated with exposure to toxigenic fungi. Bioaerosols, fungi and mycotoxins: Health effects. Assessments, prevention and control, Eckhardt Johanning. Eastern New York Center for Environmental and Occupational Health, Albany, NY 1999; 94–98
   Google Scholar
• Didricksen N. Neurocognitive deficits in individuals exposed to toxigenic molds., Presented at the 21st Annual Symposium on Man and His Environment in Health and Disease, Dallas, Texas. 19–22 June 2003
   Google Scholar
• Singer R. Neurotoxicity guidebook. Van Nostrand Reinold, New York 1990
   Google Scholar
• Anger W. K. Neurobehavorial tests and systems to assess neurotoxic exposures in the workplace and community. Occup Environ Health 2003; 60((7))531–8
   Google Scholar
• Fiedler N. Neuropsychological approaches for the detection and evaluation of toxic symptoms. Environ Health Perspect 1996; 104((Suppl 2))239–45
   PubMedGoogle Scholar
• Osterberg K., Orbaek P., Karlson B., Bergendorf U., Seger L. A comparison of neuropsychological tests for the assessment of chronic toxic encephalopathy. Am J Ind Med 2000; 38((6))666–80
   PubMed Web of Science ®Google Scholar
• Spurgeon A. Current approaches to neurobehavioural testing in occupational health. Occup Environ Med 1996; 53((11))721–5
   PubMed Web of Science ®Google Scholar
• Lang C. The use of neuroimaging techniques for clinical detection of neurotoxicity: a review. Neurotoxicology 2000; 21((5))847–56
   PubMed Web of Science ®Google Scholar
• Warwick J. M. Imaging of brain function using SPECT. Metab Brain Dis 2004; 19((1–2))113–23
   PubMed Web of Science ®Google Scholar
• Davalos D. B., Bennett T. L. A review of use of single‐photon emissions computerized tomography as a diagnostic tool in mild traumatic brain injury. Appl Neuropsychol 2002; 9((2))92–105
   PubMedGoogle Scholar
• Belanger H. G., Vanderploeg R. D., Curtiss G., Warden D. L. Recent neuroimaging techniques in mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 2007; 19((1))5–20
   PubMed Web of Science ®Google Scholar
• Metting Z., Rodinger L. A., De Keyser J., Van Der Naalt J. Structural and functional neuroimaging in mild‐to‐moderate head injury. Lancet Neurol 2007; 6((8))699–710
   PubMed Web of Science ®Google Scholar
• Zipursky R. B., Meyer J. H., Verhoeff N. P. PET and SPECT imaging in psychiatric disorders. Can J Psychiatry 2007; 52((3))146–57
   PubMed Web of Science ®Google Scholar
• Smith D. J., Cavanagh J. T. The use of single photon emission computed tomography in depressive disorders. Nucl Med Commun 2005; 26((3))197–203
   PubMed Web of Science ®Google Scholar
• Burn D. J., O'Brien J. T. Use of functional imaging in Parkinsonism and dementia. Mov Disord 2003; 18((Suppl 6))S88–95
   Google Scholar
• Small G. W., Bookheimer S. Y., Thompson P. M., Cole G. M., Huang Sc., Kepe V., Barrio J. R. Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 2008; 7((2))161–72
   PubMed Web of Science ®Google Scholar
• Callender T., Morrow L., Subramanian K., Duhon D., Ristovv M. Three‐dimensional brain metabolic imagining in patients with toxic encephalopathy. Environ Res 1993; 60((2))295–319
   PubMed Web of Science ®Google Scholar
• Fincher C., Chang T. S., Harrell E., Kettelhut M. C., REea W. J., Johnson A., Hickey D. C., Simon T. R. Comparison of single photon emission computer tomography findings in cases of healthy adults and solvent exposed adults. Am J Ind Med 1997; 31((1))4–14
   PubMed Web of Science ®Google Scholar
• Simon T. Neurotoxicity—mold exposure versus all causes., Presented at the 21st Annual Symposium on Man and His Environment in Health and Disease, Dallas, Texas. 19–22 June 2003
   Google Scholar
• Heuser G., Mena I., Alamos F. NeuroSPECT findings in patients exposed to neurotoxic chemicals. Tox Ind Health 1994; 10((4–5))561–71
   PubMed Web of Science ®Google Scholar
• Ozyurt G., Kaya F. N., Kahveci F., Alper E. Comparison of SPECT findings and neuropsychological sequelae in carbon monoxide and organophosphate poisioning. Clin Toxicol (Phila) 2008; 46((3))218–21
   PubMed Web of Science ®Google Scholar
• Chu K., Jung K. H., Kim H. J., Jeong S. W., Kang D. W., Roh J. K. Diffusion‐weighted MRI and 99mTc‐HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema. Eur Neurol 2004; 51((2))98–103
   PubMed Web of Science ®Google Scholar
• Pach D., Hubalewska A., Huszno B., Pach J. Evaluation of regional cerebral perfusion using 99mTc‐HmPAO single photon emission tomography (SPET) in carbon monoxide acutely poisoned patients. Przegl Lek 2004; 61((4))217–21
   PubMedGoogle Scholar
• Urban P., Pelclova D., Lukas E., Kupka K., Preiss J., Fenclova Z., Smerhovsky Z. Neurological and neurophysiological examinations on workers with chronic poisoning by 2,3,7,8‐TCDD: follow‐up 35 years after exposure. Eur J Neurol 2007; 14((2))213–8
   PubMed Web of Science ®Google Scholar
• Volkow N. D., Fowler J. S., Wang G. J. The addicted human brain: insights from imaging studies. J Clin Invest 2003; 111((10))1444–51
   PubMed Web of Science ®Google Scholar
• Volkow N. D., Fowler J. S., Wang G. J. Positron emission tomography and single‐photon emission computed tomography in substance abuse research. Semin Nucl Med 2003; 33((20))114–28
   PubMedGoogle Scholar
• Wang G. J., Volkow N. D., Hitzemann R., Oster Z. H., Roque C., Cestaro G. Brain imaging of an alcoholic with MRI, SPECT and PET. Am J Physiol Imag 1992; 7((3–4))194–8
   PubMedGoogle Scholar
• Demir B., Ulug B., Ergun E. L., Erbas B. Regional cerebral blood flow and neuropsychological functioning in early and late onset alcoholism. Psychiatry Res 2002; 115((3))115–25
   PubMed Web of Science ®Google Scholar
• Pavel D., Jobe T., Devore‐Best S., Davis G., Epstein P., Sinha S., Kohn R., Craita I., Liu P., Chang Y. Viewing the functional consequences of traumatic brain injury by using brain SPECT. Brain Cogn 2006; 60((2))193–217
   PubMed Web of Science ®Google Scholar
• Minoshima S., Berger K. L., Lee K. S., Mintun M. A. An automated method for rotational correction and centering of three‐dimensional functional brain images. J Nucl Med 1992; 33((8))1579
   PubMed Web of Science ®Google Scholar
• Heuser G., Mena I. Neurospect in neurotoxic chemical exposure: demonstration of long term functional abnormalities. Tox Ind Health 1998; 14((6))813–27
   PubMed Web of Science ®Google Scholar
• Schwartz R. B., Garada B. M., Komaroff A. L., Tice H. M., Gloeit M., Jolesz F. A., Holman B. L. Detection of intercranial abnormalities in patients with chronic fatigue syndrome: comparison of MR images and SPECT. AJR Am J Roentgenol 1994; 162((4))935–41
   PubMed Web of Science ®Google Scholar
• Schwartz R. B., Komaroff A. L., Garada B. M., Gleit M., Doolittle T. H., Bates D. W., Vasile R. G., Holman B. L. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex and major unipolar depression. AJR Am J Roentgenol 1994; 162((4))943–51
   PubMed Web of Science ®Google Scholar
• Guedj E., Taieb D., Cammilleri S., Lussato D., De Laforte C., Niboyet J., Mundler O. (99m)Tc‐ECD brain perfusion in hyperalgesic fibromyalgia. Eur J Nucl Med Mole Imag 2007; 34((1))130–4
   PubMed Web of Science ®Google Scholar
• Galynker I., Cai J., Ongseng F., Finestone H., Dutta E., Serseni D. Hypofrontality and negative symptoms in major depression. J Nucl Med 1998; 39((4))608–12
   PubMed Web of Science ®Google Scholar
• Gonul A. S., Kula M., Bilgn A. G., Tutus A., Oguz A. The regional cerberal blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro‐Psychopharmacol Biol Psychiatry 2004; 28((6))1015–21
   PubMed Web of Science ®Google Scholar
• Navarro V., Gasto G., Lomena F., Mateos J. J., Portella M. J., Massana G., Bernardo M., Marco T. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression. J Clin Psychiatry 2004; 65((5))656–61
   PubMed Web of Science ®Google Scholar
• Milo J. T., Kaufman G. E., Barnes E., Konopka L. M., Crayton J. W., Ringelstein J. G., Shirazi P. H. 2001. Changes in regional cerebral blood flow following electroconvulsive therapy for depression. J ECT 2001; 17((1))15–21
   PubMed Web of Science ®Google Scholar
• Bonne O., Krausz Y., Gorfine M., Karger H., Gelfin Y., Shapira B., Chisin R., Lerer B. Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. J Affect Disord 1996; 41((3))163–71
   PubMed Web of Science ®Google Scholar
• MacHale S., Lawrie S., Cavanagh J., Glabus M. F., Murray C. L., Goodwin G. M., Ebmeier K. P. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 2000; 176((6))550–6
   PubMedGoogle Scholar
• HO Pian K. L. H., Van Megen J. G. M., Ramsey N. F., Mandi R., Van Rijk P. P., Wynne H. J., Westenberg H. G. Decreased thalamic blood flow in obsessive‐compulsive patients responding to fluvoxamine. Psychiatry Res Neurmoimaging 2005; 138((2))89–97
   PubMed Web of Science ®Google Scholar
• Laliberte J. F., Meunier J., Mignotte M., Soucy J. P. Detection of diffuse abnormal perfusion in SPECT using a normal brain atlas. Neuroimage 2004; 23((2))561–8
   PubMed Web of Science ®Google Scholar
• Barnden L. R., Behin‐Ain S., Kwiatek R., Casse R., Yelland L. Age related preservation and loss in optimized brain SPECT. Nucl Med Commun 2005; 26((6))497–503
   PubMed Web of Science ®Google Scholar